Varicose vein surgery is very widely performed; the overall rate in the UK is estimated as 100,000 cases per annum, which roughly equates to one varicose vein operation per every 500 of the population each year. Therefore in very crude terms (taking into account a 20% recurrent operation rate) every member of the population has a 10% chance of having varicose vein surgery.
The outcome of surgery is undoubtedly determined by many factors, including patients' perceptions, presenting symptoms and surgeons' abilities. The rates of recurrence are often used to question the benefits of surgery, leading to further discussion about the relationship of symptoms to the underlying disease process. The number of medicolegal claims in the field is high and possibly related to unrealistic expectations of patients. The crude levels of dissatisfaction with outcomes following surgery are also important in this area. The higher levels of dissatisfaction seen among women may reflect a greater degree of expectation or a different level of disease at the time of presentation 1 .
So how should we determine the need for surgery and measure its subsequent outcome? Should it be based on a physical measurement, i.e. by the quantification of incompetence, or on the patient's perception?
Quality of life
What is quality of life? As defined by the World Health Organization in 1946, it is 'a state of complete physical, mental and social well-being, and not merely the absence of disease' 2 . However Price in 1996 described quality of life as 'the impact of an illness and its treatment on disability and daily living' 2 .
It has been well documented that quality of life assessment is of value in demonstrating the benefit of interventions to patients and can be used to focus care. To date both generic questionnaires, e.g. Modified Short Form 36 (SF-36) and disease-specific questionnaires, e.g. Aberdeen Varicose Vein Questionnaire (AVVQ), have been used in the evaluation of patients undergoing varicose vein surgery 3 -6 . Both types of assessment have shown that patients with varicose veins have a poorer quality of life compared with national norms and that patients presenting to a vascular clinic with recurrent varicose veins have a poorer quality of life compared with those presenting with primary varicose veins 5 ,6 . Surgery has been shown to significantly improve the quality of life of patients receiving treatment for both primary and recurrent disease 6 . Interestingly in many patients in whom recurrence can be demonstrated on follow-up duplex scanning, a substantial quality of life gain can still be seen 7 .
There have been attempts to amalgamate patients' subjective assessments with physicians' assessments and objective investigations. One particular example is the Venous Severity Score, which consists of two parts: the Venous Clinical Severity Score and the Venous Segmental Disease Score based on the recommendations of the 
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American Venous Forum's Ad Hoc Committee on Venous Outcomes Assessment 8 . The latter test is however time consuming and does not necessarily show any advantage over the more simplified scoring systems such as the AVVQ 9 . The next challenge in this area will be to use a scoring system, ideally patient administered, which could identify a cohort of patients most likely to benefit from surgical intervention and which may be a way of prioritizing patient care. Another use for a simple scoring system would be to allow unified reporting of outcomes and quality control between different institutions, and to potentially evaluate the outcomes of the different techniques of varicose vein ablation. The benefit of venous surgery to the population can be calculated from the cost of a given improvement in quality of life and this can be used when accessing clinical priorities.
The editor would like to pose two questions:
1. Is evaluation of patients with such tools important? 2. How should we view a patient who has a poorer score in an objective investigation (e.g. duplex) but has a marked improvement in a quality of life score, which many would regard as a subjective outcome measure?
I would like to receive peoples' views on the above and publish some of them in the next issue.
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